cannabis indica

Dor — Aguda

termo de indexação original: Pain - Acute

O acervo do Cannabis Indica reúne 222 estudos científicos que tocam a condição Dor — Aguda, publicados entre 1843 e 2024. Pela leitura automatizada, 161 (73%) foram classificados como favoráveis, 36 (16%) como inconclusivos e 25 (11%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (97 estudos), seguido de estudo em animais (59). Os compostos mais presentes são Tetraidrocanabinol (THC), Anandamida (AEA) e Endocanabinoide (não especificado). Aparece com frequência ao lado de Dor, Dor — Crônica e Inflamação.

Estudos indexados
222
Período coberto
1843–2024
Favoráveis
161 · 73%
Inconclusivos
36 · 16%
Desfavoráveis
25 · 11%
Termo original
Pain - Acute

O acervo em números

Tipo de estudo

Metanálise97
Estudo em Animais59
Ensaio Clínico Duplo-Cego34
Estudo Laboratorial13
Ensaio Clínico11
Metanálise Clínica8

Direção do resultado

Favorável161
Inconclusivo36
Desfavorável25

Por década

1840s2
1880s1
1970s1
1980s1
1990s4
2000s28
2010s57
2020s128

222 estudos

Filtrar e buscar no acervo →
  1. 2024

    Association between history of cannabis use and outcomes after total hip or knee arthroplasty: a systematic review and meta-analysis

    DesfavorávelMetanáliseDorDor — CrônicaCicatrização
  2. 2024

    Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

    InconclusivoMetanáliseDorAnandamida (AEA)Tetraidrocanabinol (THC)+8
  3. 2023

    A Case of a Patient With Cannabis Hyperemesis Syndrome Along With Recurrent Nephrolithiasis

    DesfavorávelMetanáliseDorInflamaçãoEfeitos Adversos da Cannabis+7
  4. 2023

    A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)

    FavorávelEnsaio Clínico Duplo-CegoDorEndocanabinoide (não especificado)Canabigerol (CBG)
  5. 2023

    Additive or synergistic analgesic effect of metamizole on standard pain treatment at home after arthroscopic shoulder surgery: A randomised controlled superiority trial

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoDependência — OpioidesEndocanabinoide (não especificado)
  6. 2023

    Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin®) site pain: a case report

    FavorávelMetanáliseDorInflamaçãoAnsiedade+3
  7. 2023

    Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms

    DesfavorávelMetanálise ClínicaDor — CrônicaDor — Neuropatia PeriféricaDor — Oncológica+6
  8. 2023

    Cannabidiol as an Alternative Analgesic for Acute Dental Pain

    FavorávelEnsaio Clínico Duplo-CegoDorDoença PeriodontalCáriesCBD Farmacêutico+1
  9. 2023

    Cannabinoid Hyperemesis Syndrome in a 23-Year-Old Woman with Uncontrolled Type 1 Diabetes Mellitus

  10. 2023

    Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis

    InconclusivoMetanálise ClínicaDorDependência QuímicaCâncer+15
  11. 2023

    Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+7
  12. 2023

    Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoInfecções Bacterianas+2
  13. 2023

    Dramatic efficacy of cannabidiol on refractory chronic pain in an adolescent with sickle cell disease

  14. 2023

    Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoCálculos RenaisCBD Farmacêutico
  15. 2023

    Marijuana as a Cause of Diffuse Coronary Vasospasm Leading to Cardiac Arrest

  16. 2023

    Poster 186: Cannabidiol for Post-Operative Pain Control after Arthroscopic Rotator Cuff Repair Demonstrates No Functional Deficits at 1-Year

    FavorávelEnsaio Clínico Duplo-CegoDorCBD Farmacêutico
  17. 2023

    Sudden Cardiac Arrest in Patient With Ventricular Septal Defect and Marijuana Consumption: A Case Report and Review of Literature

  18. 2023

    Synthetic Cannabinoids and ST-Elevated Myocardial Infarction: A Case Report and Literature Review

  19. 2023

    Weeding Out the Culprit: Cannabinoid-Associated Stevens-Johnson Syndrome

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisAnsiedade+4
  20. 2022

    A Coala-T-Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment

    FavorávelMetanáliseDorCâncerAnsiedade+5
  21. 2022

    A critical review of cannabis in medicine and dentistry: A look back and the path forward

    InconclusivoMetanáliseDorInflamaçãoCáries
  22. 2022

    Anti-neuropathic pain mechanistic study of A. conyzoides essential oil, Precocene II, Caryophyllene, or Longifolene as single agent and in combination with pregabalin

    FavorávelEstudo em AnimaisDorDor — CrônicaDor — Neuropatia Periférica
  23. 2022

    Antinociceptive, anti-inflammatory, and cytotoxic properties of Origanum vulgare essential oil, rich with β-caryophyllene and β-caryophyllene oxide

    FavorávelEstudo em AnimaisDorInflamação
  24. 2022

    Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica+3
  25. 2022

    Cannabinoids in the Orthopedic Setting: A Literature Review

    DesfavorávelMetanáliseDorDor — CrônicaDependência — Opioides+6
  26. 2022

    Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaCanabinol (CBN)+5
  27. 2022

    Could Palmitoylethanolamide Be an Effective Treatment for Long-COVID-19? Hypothesis and Insights in Potential Mechanisms of Action and Clinical Applications

  28. 2022

    Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence

  29. 2022

    Current Cannabidiol Safety: A Review

    FavorávelMetanáliseDorCâncerInflamação+10
  30. 2022

    Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions

    InconclusivoMetanáliseDorAnsiedadeAnandamida (AEA)Exercício Físico
  31. 2022

    Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice

    InconclusivoEstudo em AnimaisDorDor — CrônicaDependência — Opioides
  32. 2022

    Experience With Medical Marijuana for Cancer Patients in the Palliative Setting

    FavorávelMetanáliseDorCâncerDor — Crônica+2
  33. 2022

    Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966

  34. 2022

    Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

    FavorávelMetanáliseDorDor — CrônicaCanabigerol (CBG)
  35. 2022

    Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I)

    InconclusivoEnsaio Clínico Duplo-CegoDorCBD Farmacêutico
  36. 2022

    Pharmacological effects of cannabidiol by transient receptor potential channels

    FavorávelMetanáliseDorCâncerInflamação+5
  37. 2022

    Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot

  38. 2022

    Role of Cannabinoids in Various Diseases: A Review

  39. 2022

    Self-Reported Cannabis Use Is Associated With a Lower Rate of Persistent Opioid Use After Total Joint Arthroplasty

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+1
  40. 2022

    Sex differences in medical cannabis-related adverse effects

  41. 2022

    Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

  42. 2022

    The cannabinoid receptor I (CB1) enhanced the osteogenic differentiation of BMSCs by rescue impaired mitochondrial metabolism function under inflammatory condition

    FavorávelEstudo LaboratorialDorInflamaçãoDoença PeriodontalEndocanabinoide (não especificado)+1
  43. 2022

    The Effect of Palmitoylethanolamide on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers-A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnandamida (AEA)Palmitoiletanolamida (PEA)
  44. 2022

    The effects of collagen peptides on exercise-induced gastrointestinal stress: a randomized, controlled trial

  45. 2022

    Topical Cannabidiol (CBD) After Total Knee Arthroplasty Does Not Decrease Pain or Opioid Use: A Prospective Randomized Double-Blinded Placebo-Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaDependência — Opioides+1
  46. 2022

    Viphyllin TM, a Standardized Black Pepper Seed Extract Exerts Antinociceptive Effects in Murine Pain Models via Activation of Cannabinoid Receptor CB2, Peroxisome Proliferator-Activated Receptor-Alpha and TRPV1 Ion Channels

    FavorávelEstudo em AnimaisDor
  47. 2021

    [Cannabis and cannabinoids for the treatment of acute and chronic pain]

    InconclusivoMetanáliseDorDor — Crônica
  48. 2021

    Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol

    FavorávelMetanáliseDorDependência QuímicaInflamação+7
  49. 2021

    Analgesic Potential of Terpenes Derived from Cannabis sativa

    FavorávelMetanáliseDorCâncerInflamaçãoEquinácea+5
  50. 2021

    Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians

    FavorávelMetanáliseDorInflamaçãoDor — Crônica+1
  51. 2021

    Antinociceptive Activity of Compounds from the Aqueous Extract of Melampodium divaricatum

    FavorávelEstudo em AnimaisDorOutros Compostos Relacionados
  52. 2021

    Antinociceptive and Anti-Inflammatory Properties of Cannabidiol Alone and in Combination with Standardized Bioflavonoid Composition

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica
  53. 2021

    Antinociceptive effects of minor cannabinoids, terpenes and flavonoids in Cannabis

    FavorávelMetanáliseDorDor — Crônica
  54. 2021

    Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+5
  55. 2021

    Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors

    FavorávelEstudo em AnimaisDorAnsiedadeDor — Crônica+1
  56. 2021

    Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain

    FavorávelMetanáliseDorDor — Crônica
  57. 2021

    Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels

    FavorávelEstudo em AnimaisDorDor — Nociceptiva
  58. 2021

    Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation

    FavorávelMetanáliseDorInflamaçãoAnsiedade+4
  59. 2021

    Cannabinoid and Opioid Use Among Total Joint Arthroplasty Patients: A 6-Year, Single-Institution Study

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+2
  60. 2021

    Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations

    InconclusivoEstudo em AnimaisDor
  61. 2021

    Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies

    FavorávelMetanáliseDor
  62. 2021

    Cannabinoids in dermatologic surgery

    FavorávelMetanáliseDorInflamaçãoCicatrização
  63. 2021

    Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials

  64. 2021

    Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

    InconclusivoMetanálise ClínicaDorDor — CrônicaDor — Neuropatia Periférica+4
  65. 2021

    Cannabis and pain: a scoping review

    InconclusivoMetanáliseDorDor — CrônicaDor — Oncológica
  66. 2021

    Cannabis-based medicines and pain: a review of potential synergistic and entourage effects

    FavorávelMetanáliseDorDor — Crônica
  67. 2021

    Chronic Treatment with Cannabidiolic Acid (CBDA) Reduces Thermal Pain Sensitivity in Male Mice and Rescues the Hyperalgesia in a Mouse Model of Rett Syndrome

    FavorávelEstudo em AnimaisDorAnsiedadeDor — CrônicaÁcido Canabidiólico (CBD-a)+4
  68. 2021

    Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB 2 Receptor Derived from the Natural Product Cannabidiol

    FavorávelEstudo LaboratorialDorInflamaçãoEfeitos Adversos da Cannabis+2
  69. 2021

    Dose-Related Inhibition of Capsaicin Responses by Cannabinoids CBG, CBD, THC and their Combination in Cultured Sensory Neurons

    FavorávelEstudo LaboratorialDorDor — CrônicaCanabigerol (CBG)Canabicromeno (CBC)+1
  70. 2021

    Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department

  71. 2021

    Evaluation of the analgesic potential and safety of Cinnamomum camphora chvar. Borneol essential oil

    FavorávelEstudo em AnimaisDor
  72. 2021

    Experimental therapies in Irritable Bowel Syndrome

  73. 2021

    High and Mighty? Cannabinoids and the microbiome in pain

  74. 2021

    Inhibition of sodium conductance by cannabigerol contributes to a reduction of dorsal root ganglion neuron excitability

    FavorávelEstudo LaboratorialDorCanabigerol (CBG)
  75. 2021

    International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management

    FavorávelMetanáliseDorDor — CrônicaDor — Neuropatia Periférica+5
  76. 2021

    Investigation of antinociceptive, antipyretic, antiasthmatic, and spasmolytic activities of Brazilian Cannabis sativa L. roots in rodents

    FavorávelEstudo em AnimaisDorInflamaçãoAsma
  77. 2021

    Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell

    FavorávelEstudo LaboratorialDorCáriesDor — Dentária Aguda
  78. 2021

    Limonene, a citrus monoterpene, non-complexed and complexed with hydroxypropyl-β-cyclodextrin attenuates acute and chronic orofacial nociception in rodents: Evidence for involvement of the PKA and PKC pathway

    FavorávelEstudo em AnimaisDorDor — Crônica
  79. 2021

    Linalool odor‐induced analgesia is triggered by TRPA1-independent pathway in mice

    FavorávelEstudo em AnimaisDor
  80. 2021

    Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+1
  81. 2021

    Orexinergic descending inhibitory pathway mediates linalool odor-induced analgesia in mice

    FavorávelEstudo em AnimaisDor
  82. 2021

    Pain Profiles among Young Adult Cannabis Users: An Analysis of Antecedent Factors and Distal Outcomes

    FavorávelMetanáliseDorDor — CrônicaInsônia e Distúrbios do Sono
  83. 2021

    Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain

    FavorávelEstudo em AnimaisDorDor — Crônica
  84. 2021

    Perioperative Cannabis as a Potential Solution for Reducing Opioid and Benzodiazepine Dependence

    FavorávelMetanáliseDorDependência QuímicaCâncer+3
  85. 2021

    Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process

    InconclusivoMetanáliseDorNáusea e Vômito
  86. 2021

    Potential Role of Cannabidiol on Sports Recovery: A Narrative Review

    FavorávelMetanáliseDorAnsiedadeDisfunção Cognitiva+2
  87. 2021

    Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  88. 2021

    Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty

    InconclusivoMetanáliseDor
  89. 2021

    The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain

    InconclusivoEnsaio Clínico Duplo-CegoDor
  90. 2021

    The Current and Potential Application of Medicinal Cannabis Products in Dentistry

  91. 2021

    The dose-dependent analgesic effects, abuse liability, safety and tolerability of oral cannabidiol in healthy humans

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaDor — Nociceptiva
  92. 2021

    The effect of oral Δ-9-tetrahydrocannabinol on the minimal alveolar concentration of sevoflurane A randomised, controlled, observer-blinded experimental study

    DesfavorávelEstudo em AnimaisDorAnsiedade
  93. 2021

    The Effectiveness of Cannabis and Cannabis Derivatives in Treating Lower Back Pain in the Aged Population: A Systematic Review

    InconclusivoMetanáliseDorAnsiedadeDor — CrônicaTHC FarmacêuticoCBD Farmacêutico+2
  94. 2021

    The Effects of Cannabidiol Oil on Noninvasive Measures of Muscle Damage in Men

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamação
  95. 2021

    The Effects of Cannabis: Implications for the Surgical Patient

    InconclusivoMetanáliseDorCicatrização
  96. 2021

    The Endocannabinoid System Contributes to Electroacupuncture Analgesia

    FavorávelMetanáliseDorInflamaçãoDor — Crônica
  97. 2021

    The Physiological Effects, Including Risks and Potential Benefits, of Cannabis for Patients Undergoing Elective Orthopedic Procedures

    InconclusivoMetanáliseDor
  98. 2021

    The Use of Cannabis and Cannabinoid-based Products by Pregnant Women: A Patent Review

    FavorávelMetanáliseDorInflamaçãoNáusea e Vômito+1
  99. 2021

    Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain

  100. 2021

    Treating pain related to Ehlers-Danlos syndrome with medical cannabis

    FavorávelMetanáliseDorDor — CrônicaSíndrome de Ehlers-Danlos
  101. 2021

    Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaTHC Farmacêutico
  102. 2020

    19-Year-Old Man With Fevers, Abdominal Pain, and Cough

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisNáusea e Vômito+2
  103. 2020

    A Comprehensive Patient and Public Involvement Program Evaluating Perception of Cannabis-Derived Medicinal Products in the Treatment of Acute Postoperative Pain, Nausea, and Vomiting Using a Qualitative Thematic Framework

    FavorávelMetanáliseDorNáusea e Vômito
  104. 2020

    A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain

    FavorávelMetanáliseDorDor — CrônicaDor — Neuropatia Periférica+1
  105. 2020

    A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome

    FavorávelEnsaio Clínico Duplo-CegoDorNáusea e VômitoSíndrome da Hiperêmese CanabinoideCapsaicina (CAPS)+1
  106. 2020

    A Scoping Review on Clinical Trials of Pain Reduction With Cannabis Administration in Adults

    InconclusivoMetanálise ClínicaDorDor — CrônicaEsclerose Múltipla+3
  107. 2020

    Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis

    DesfavorávelMetanálise ClínicaDor
  108. 2020

    Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review

    FavorávelMetanáliseDorDor — Crônica
  109. 2020

    Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research

    FavorávelMetanáliseDorInflamaçãoAnsiedade+6
  110. 2020

    Cannabidiol: A Brief Review of Its Therapeutic and Pharmacologic Efficacy in the Management of Joint Disease

    FavorávelMetanáliseDorDor — CrônicaArtrite+1
  111. 2020

    Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial

    DesfavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeNáusea e VômitoTHC Farmacêutico+1
  112. 2020

    Cannabinoids in the Management of Acute Pain: A Systematic Review and Meta-analysis

    FavorávelMetanáliseDor
  113. 2020

    CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons

    FavorávelEstudo LaboratorialDorDor — Crônica
  114. 2020

    CBD for the treatment of pain: What is the evidence?

    InconclusivoMetanáliseDorDor — Crônica
  115. 2020

    Cholesterol regulates cannabinoid analgesia through glycine receptors

    FavorávelEstudo em AnimaisDorDor — Crônica
  116. 2020

    Daring discourse - no: cannabinoids should not be used for acute postoperative pain management

    InconclusivoMetanáliseDor
  117. 2020

    Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaDependência — Opioides+1
  118. 2020

    Efficacy of Dronabinol for Acute Pain Management in Adults with Traumatic Injury: Study Protocol of A Randomized Controlled Trial

  119. 2020

    In an exploratory randomized, double-blind, placebo-controlled, cross-over study, psychoactive doses of intravenous delta-9-tetrahydrocannabinol fail to produce antinociceptive effects in healthy human volunteers

    DesfavorávelEnsaio Clínico Duplo-CegoDorCapsaicina (CAPS)
  120. 2020

    Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury

    FavorávelMetanáliseDorTHC Farmacêutico
  121. 2020

    Myocardial ischaemia associated with tetrahydrocannabinol intake in a teenage boy: A case report

  122. 2020

    No Evidence of Altered Reactivity to Experimentally Induced Pain Among Regular Cannabis Users

    FavorávelEnsaio ClínicoDor
  123. 2020

    Small bowel intussusception in marijuana users

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+6
  124. 2020

    Terpenes/Terpenoids in Cannabis: Are They Important?

    FavorávelMetanáliseDorCâncerInflamação+10
  125. 2020

    The Cannabis Terpenes

    FavorávelMetanáliseDorCâncerInflamação+10
  126. 2020

    The Effect of Orally Dosed Levagen+™ (palmitoylethanolamide) on Exercise Recovery in Healthy Males—A Double-Blind, Randomized, Placebo-Controlled Study

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoPalmitoiletanolamida (PEA)
  127. 2020

    The Protective Effects of Pre- and Post-Administration of Micronized Palmitoylethanolamide Formulation on Postoperative Pain in Rats

    FavorávelEstudo em AnimaisDorInflamaçãoPalmitoiletanolamida (PEA)
  128. 2020

    Understanding Cannabis-Based Therapeutics in Sports Medicine

    FavorávelMetanáliseDorDor — CrônicaEstresse Oxidativo+4
  129. 2019

    Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: impact of drug and fixed-dose ratio

  130. 2019

    Cannabichromene is a cannabinoid CB2 receptor agonist

    FavorávelEstudo LaboratorialDorInflamaçãoCanabinoides Sintéticos AM-xCanabicromeno (CBC)+1
  131. 2019

    Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data

    InconclusivoMetanáliseDorDor — CrônicaDependência — Opioides
  132. 2019

    Involvement of Spinal Cannabinoid CB 2 Receptors in Exercise-Induced Antinociception

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica
  133. 2019

    Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity

  134. 2019

    Myrcene and terpene regulation of TRPV1

    FavorávelEstudo LaboratorialDorDor — CrônicaDor — Nociceptiva
  135. 2019

    Opioid-enhancing antinociceptive effects of delta-9-tetrahydrocannabinol and amitriptyline in rhesus macaques

    FavorávelEstudo em AnimaisDorDependência QuímicaDor — CrônicaCanabinoides Sintéticos SR-x+2
  136. 2019

    Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State

    InconclusivoMetanáliseDorCâncerDor — Crônica
  137. 2019

    Prescription Pain Reliever Use and Misuse among Cannabis Users Aged 50+ Years

    DesfavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  138. 2019

    US Veterinarians' Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+16
  139. 2018

    (+)-Borneol suppresses conditioned fear recall and anxiety-like behaviors in mice

    FavorávelEstudo em AnimaisDorAnsiedade
  140. 2018

    Antinociceptive effects of JWH015 in female and male rats

  141. 2018

    Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception

    FavorávelEstudo em AnimaisDorTetraidrocanabinol (THC)
  142. 2018

    Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia

    FavorávelEnsaio Clínico Duplo-CegoDorAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  143. 2018

    Role of l-arginine/SNAP/NO/cGMP/K ATP Channel Signalling Pathway in Antinociceptive Effect of α-Terpineol in Mice

    FavorávelEstudo em AnimaisDorDor — CrônicaDor — Nociceptiva
  144. 2017

    A clinical and mechanistic study of topical borneol‐induced analgesia.

    FavorávelEnsaio Clínico Duplo-CegoDor
  145. 2017

    A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery

  146. 2017

    Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.

    FavorávelEstudo em AnimaisDor
  147. 2017

    Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity.

    FavorávelEstudo em AnimaisDorTetraidrocanabinol (THC)
  148. 2017

    Cannabinoids and Pain: Sites and Mechanisms of Action.

  149. 2017

    Cannabis as a substitute for prescription drugs - a cross-sectional study.

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+1
  150. 2017

    Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis

  151. 2017

    How Does Marijuana Effect Outcomes After Trauma In ICU Patients? A Propensity Matched Analysis

    FavorávelMetanáliseDor
  152. 2017

    N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities

    FavorávelEstudo LaboratorialDorInflamaçãoDor — CrônicaN-Araquidonoil Dopamina (NADA)+1
  153. 2017

    Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

  154. 2017

    Recent advances in the endocrinology of the sebaceous gland

  155. 2017

    The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+7
  156. 2017

    Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+5
  157. 2016

    An update on PPAR activation by cannabinoids

  158. 2016

    Association of Terpinolene and Diclofenac Presents Antinociceptive and Anti-Inflammatory Synergistic Effects in a Model of Chronic Inflammation

    FavorávelEstudo em AnimaisDorInflamaçãoDor — Crônica
  159. 2016

    Dronabinol increases pain threshold in patients with functional chest pain: a pilot double-blind placebo-controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeDepressãoTetraidrocanabinol (THC)THC Farmacêutico+2
  160. 2016

    Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

  161. 2016

    Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)
  162. 2016

    Palmitoylethanolamide Reverses Paclitaxel-Induced Allodynia in Mice

  163. 2015

    A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial

    FavorávelEnsaio Clínico Duplo-CegoDorDoenças Cardiovasculares (DCV)Síndrome MetabólicaTHC Farmacêutico+3
  164. 2015

    A runner’s high depends on cannabinoid receptors in mice

  165. 2015

    Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix

    FavorávelEnsaio Clínico Duplo-CegoDorTetraidrocanabinol (THC)
  166. 2015

    Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal

  167. 2015

    Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice

    FavorávelEstudo em AnimaisDorDor — Crônica
  168. 2015

    Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study

    FavorávelEstudo em AnimaisDorInflamaçãoAplicações VeterináriasPalmitoiletanolamida (PEA)+4
  169. 2015

    Endocannabinoids and Acute Pain Following Total Knee Arthroplasty

    FavorávelMetanáliseDorCicatrização2-Araquidonoilglicerol (2-AG)
  170. 2015

    Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome

  171. 2014

    Cannabinoid Receptor Type 1 Antagonist, AM-251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury

    FavorávelEstudo em AnimaisDorInflamaçãoQueimadurasCanabinoides Sintéticos AM-x
  172. 2014

    Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea

  173. 2014

    Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain

    FavorávelEstudo em AnimaisDor
  174. 2014

    Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat

    FavorávelEstudo em AnimaisDorTetraidrocanabinol (THC)
  175. 2014

    Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints

  176. 2013

    Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

  177. 2013

    Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study

  178. 2013

    Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE)

  179. 2012

    Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase

    InconclusivoEstudo em AnimaisDorHidrolase de Amidas de Ácidos Graxos (FAAH)
  180. 2012

    Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems

  181. 2012

    The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaCanabinoides Sintéticos O-x+1
  182. 2011

    Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain

  183. 2011

    The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaN-Araquidonoil Dopamina (NADA)
  184. 2010

    A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

    FavorávelEstudo em AnimaisDorAnsiedadeDisfunção CognitivaTetraidrocanabinol (THC)+4
  185. 2010

    Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain

  186. 2009

    Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

  187. 2009

    CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents

  188. 2009

    Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats

    FavorávelEstudo em AnimaisDorInflamaçãoDor — CrônicaAnandamida (AEA)Acupuntura (MTC)
  189. 2008

    Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia

    FavorávelEstudo em AnimaisDorTetraidrocanabinol (THC)Canabinoides Sintéticos WIN-x
  190. 2008

    Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers

    InconclusivoEnsaio Clínico Duplo-CegoDorQueimadura SolarTetraidrocanabinol (THC)
  191. 2007

    Dose-dependent Effects of Smoked Cannabis on Capsaicin-Induced Pain and Hyperalgesia in Healthy Volunteers

    InconclusivoEnsaio Clínico Duplo-CegoDorCapsaicina (CAPS)
  192. 2007

    Treatment with lavender aromatherapy in the post-anesthesia care unit reduces opioid requirements of morbidly obese patients undergoing laparoscopic adjustable gastric banding.

    FavorávelEnsaio Clínico Duplo-CegoDorDependência — Opioides
  193. 2006

    A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management.

    FavorávelEnsaio ClínicoDor
  194. 2006

    Delta(9)-tetrahydrocannabinol and the Opioid Receptor Agonist Piritramide Do Not Act Synergistically in Postoperative Pain

    InconclusivoEnsaio Clínico Duplo-CegoDorTetraidrocanabinol (THC)THC Farmacêutico
  195. 2006

    Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine.

    FavorávelEnsaio Clínico Duplo-CegoDorDependência QuímicaDependência — OpioidesTetraidrocanabinol (THC)
  196. 2005

    (+)- And (-)-borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA(A) receptors

    FavorávelEstudo LaboratorialDor
  197. 2005

    Cannabinoid CB2 Receptor Agonist Activity in the Hindpaw Incision Model of Postoperative Pain

  198. 2005

    Delta9-tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice

  199. 2005

    Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals

    FavorávelMetanáliseDorInflamaçãoPalmitoiletanolamida (PEA)
  200. 2005

    The search for the palmitoylethanolamide receptor

  201. 2004

    Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC

    DesfavorávelEstudo em AnimaisDorEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  202. 2004

    Synergistic interactions between cannabinoid and opioid analgesics

  203. 2003

    CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

  204. 2003

    Efficacy of two cannabis‐based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

  205. 2003

    Exercise activates the endocannabinoid system

    FavorávelMetanáliseDorEndocanabinoide (não especificado)Exercício Físico
  206. 2003

    Inhibition of acetylcholine-mediated effects by borneol

    FavorávelEstudo LaboratorialDor
  207. 2003

    Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.

    InconclusivoEnsaio Clínico Duplo-CegoDorTetraidrocanabinol (THC)
  208. 2002

    Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration

    DesfavorávelEstudo em AnimaisDorAnandamida (AEA)Tetraidrocanabinol (THC)+2
  209. 2002

    Endocannabinoids and related fatty acid derivatives in pain modulation

  210. 2001

    Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice

  211. 2001

    Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

    DesfavorávelMetanálise ClínicaDor — CrônicaDor — Oncológica
  212. 2000

    Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats

  213. 2000

    Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide

    FavorávelEstudo em AnimaisDorAnandamida (AEA)Canabinoides Sintéticos CP-x
  214. 1999

    Cannabinoids as antioxidants and neuroprotectants.

  215. 1999

    Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

    FavorávelEstudo em AnimaisDorDependência QuímicaDoenças Cardiovasculares (DCV)+2
  216. 1998

    Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla

    FavorávelEstudo em AnimaisDorDor — CrônicaCanabinoides Sintéticos HU-x
  217. 1993

    Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids

    InconclusivoEstudo LaboratorialDorDor — CrônicaCanabinoides Sintéticos WIN-x
  218. 1981

    Evaluation of intramuscular levonantradol and placebo in acute postoperative pain.

    FavorávelEnsaio Clínico Duplo-CegoDorTetraidrocanabinol (THC)Canabinoide Sintético (não especificado)+1
  219. 1977

    Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.

    InconclusivoEnsaio Clínico Duplo-CegoDorCicatrizaçãoSíndrome de Ehlers-Danlos
  220. 1885

    Cannabis Indica

    FavorávelMetanáliseDorCáriesDor — Dentária Aguda
  221. 1849

    Indian Hemp in Facial Neuralgia

    FavorávelMetanáliseDorDor — CrônicaDor — Neuropatia Periférica
  222. 1843

    Observations on the medicinal properties of the Cannabis Sativa of India

    FavorávelMetanáliseDorCâncerDepressão+10

Continue por aqui

Perguntas frequentes

Quantos estudos sobre dor — aguda estão indexados no acervo?
São 222 estudos, publicados entre 1843 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 97 · Estudo em Animais: 59 · Ensaio Clínico Duplo-Cego: 34 · Estudo Laboratorial: 13 · Ensaio Clínico: 11 · Metanálise Clínica: 8. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 161 favoráveis, 36 inconclusivos e 25 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Dor — Aguda — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/dor-aguda/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Dor — Aguda — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/dor-aguda/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.